Systemic inflammatory and immune milieu

The systemic inflammatory and immune milieu refers to the collective state of circulating cytokines, chemokines, and immune cells that define an individual's overall inflammatory profile (StatPearls: Inflammation). It is not a single molecular target but rather a complex physiological environment that significantly influences the pathogenesis and progression of various diseases, including cancer, cardiovascular disorders, and autoimmune conditions (Nature Reviews Cancer: Inflammation and cancer). In oncology, a pro-inflammatory milieu is often associated with poor prognosis, as it can facilitate tumor evasion and metastasis (Journal of Hematology & Oncology: Systemic immune-inflammation index). Therapeutic strategies aimed at this milieu involve the use of broad-spectrum immunomodulators or specific cytokine inhibitors to shift the systemic environment from a chronic inflammatory state toward homeostasis (NIH: The systemic inflammatory response). Monitoring this milieu is typically achieved through composite biomarkers such as the neutrophil-to-lymphocyte ratio (NLR) or the Systemic Immune-Inflammation Index (SII) (PubMed: Biomarkers of systemic inflammation). Understanding the dynamics of this milieu is essential for predicting patient responses to immunotherapy and managing systemic inflammatory conditions.

Other names

Systemic immune-inflammatory statusSystemic inflammatory responseImmune-inflammatory microenvironmentSystemic immune-inflammatory landscape

Systemic modulation of cytokine networks and immune cell populations to restore immune homeostasis